Nebulized Budesonide

ApprovedSmall molecule

DDeborah Gentile

Nebulized Budesonide is one of 54 small molecule programs targeting Wheezing. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

WheezingActive, not recruiting

AsthmaActive, not recruiting

HypertrophyActive, not recruiting

WheezingApproved

Active, not recruiting

AsthmaPhase 3

Active, not recruiting

HypertrophyPhase 3

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Nebulized Budesonide

DDeborah Gentile

Approved

2 2

Cinqair

Teva

Preclinical

13 3

Spiriva

Boehringer Ingelheim

Preclinical

8 4

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 5

Atrovent

Boehringer Ingelheim

Preclinical

5 6

Formoterol Fumarate

AstraZeneca

Preclinical

8 7

Symbicort

AstraZeneca

Preclinical

6 8

Aciphex

Akero Therapeutics

Preclinical

2 9

Atrovent

Boehringer Ingelheim

Preclinical

2 10

Decadron

QQuince Therapeutics S.p.A.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma2 trials

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Unknown status·HHamad Medical Corporation·Phase 3·NCT02455687·240 enrolled

Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

Completed·—·Phase 4·NCT00522782·16 enrolled

Wheezing1 trial

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

Completed·DDeborah Gentile·Phase 4·NCT00189436·61 enrolled

Hypertrophy1 trial

Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy

Unknown status·SSecond Xiangya Hospital of Central South University·Phase 3·NCT05325489·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Nebulized Budesonide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nebulized Budesonide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nebulized Budesonide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Deborah Gentile company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: DDeborah Gentile

Nebulized Budesonide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma2 trials

Wheezing1 trial

Hypertrophy1 trial

References

Drug Info

Quick Facts

Related News